Cytokinetics, Incorporated (CYTK) shares gained 4.11% today (2023-12-11). Is it the right time to buy?

What’s happening at Cytokinetics, Incorporated (NasdaqGS:CYTK)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 4.11% (or 1.40 points) to $35.50 from its previous close of $34.10. So is it the right moment to buy?
Read more: Cytokinetics, Incorporated (CYTK) shares gained 4.11% today (2023-12-11). Is it the right time to buy?